Cargando…

Plasmodium berghei K13 Mutations Mediate In Vivo Artemisinin Resistance That Is Reversed by Proteasome Inhibition

The recent emergence of Plasmodium falciparum parasite resistance to the first line antimalarial drug artemisinin is of particular concern. Artemisinin resistance is primarily driven by mutations in the P. falciparum K13 protein, which enhance survival of early ring-stage parasites treated with the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Simwela, Nelson V., Stokes, Barbara H., Aghabi, Dana, Bogyo, Matt, Fidock, David A., Waters, Andrew P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667033/ https://www.ncbi.nlm.nih.gov/pubmed/33173001 http://dx.doi.org/10.1128/mBio.02312-20

Ejemplares similares

Experimentally Engineered Mutations in a Ubiquitin Hydrolase, UBP-1, Modulate In Vivo Susceptibility to Artemisinin and Chloroquine in Plasmodium berghei
por: Simwela, Nelson V., et al.
Publicado: (2020)

Mutation in the Plasmodium falciparum BTB/POZ Domain of K13 Protein Confers Artemisinin Resistance
por: Paloque, Lucie, et al.
Publicado: (2022)

Implications of Glutathione Levels in the Plasmodium berghei Response to Chloroquine and Artemisinin
por: Vega-Rodríguez, Joel, et al.
Publicado: (2015)

Insights into the intracellular localization, protein associations and artemisinin resistance properties of Plasmodium falciparum K13
por: Gnädig, Nina F., et al.
Publicado: (2020)

Artemisinin-resistant K13 mutations rewire Plasmodium falciparum’s intra-erythrocytic metabolic program to enhance survival
por: Mok, Sachel, et al.
Publicado: (2021)

A Study of Synergy of Combination of Eosin B with Chloroquine, Artemisinin, and Sulphadoxine-Pyrimethamine on Plasmodium falciparum In Vitro and Plasmodium berghei In Vivo
por: Sadeghi, Sedigheh, et al.
Publicado: (2020)

Plasmodium falciparum K13 mutations in Africa and Asia impact artemisinin resistance and parasite fitness
por: Stokes, Barbara H, et al.
Publicado: (2021)

Plasmodium falciparum resistance to artemisinin-based combination therapies
por: Ward, Kurt E, et al.
Publicado: (2022)

Polymorphisms in the K13-Propeller Gene in Artemisinin-Resistant Plasmodium in Mice
por: Zheng, Shaoqin, et al.
Publicado: (2022)

Local emergence in Amazonia of Plasmodium falciparum k13 C580Y mutants associated with in vitro artemisinin resistance
por: Mathieu, Luana C, et al.
Publicado: (2020)

Novel Mutations in K13 Propeller Gene of Artemisinin-Resistant Plasmodium falciparum
por: Isozumi, Rie, et al.
Publicado: (2015)

Covalent Plasmodium falciparum-selective proteasome inhibitors exhibit a low propensity for generating resistance in vitro and synergize with multiple antimalarial agents
por: Stokes, Barbara H., et al.
Publicado: (2019)

Plasmodium falciparum K13 Mutations Differentially Impact Ozonide Susceptibility and Parasite Fitness In Vitro
por: Straimer, Judith, et al.
Publicado: (2017)

Artemisinin-Resistant Plasmodium falciparum K13 Mutant Alleles, Thailand–Myanmar Border
por: Boullé, Mikael, et al.
Publicado: (2016)

Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda
por: Uwimana, Aline, et al.
Publicado: (2020)

Improved negative selection protocol for Plasmodium berghei in the rodent malarial model
por: Orr, Rachael Y, et al.
Publicado: (2012)

In Vivo Hemozoin Kinetics after Clearance of Plasmodium berghei Infection in Mice
por: Frita, Rosangela, et al.
Publicado: (2012)

In vivo Antimalarial Activities of Russelia Equisetiformis in Plasmodium Berghei Infected Mice
por: Ojurongbe, O., et al.
Publicado: (2015)

The crystal structures of macrophage migration inhibitory factor from Plasmodium falciparum and Plasmodium berghei
por: Dobson, Sarah E, et al.
Publicado: (2009)

Author Correction: Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda
por: Uwimana, Aline, et al.
Publicado: (2021)

Identification of Potent and Selective Non-covalent Inhibitors of the Plasmodium falciparum Proteasome
por: Li, Hao, et al.
Publicado: (2014)

Polymorphisms of the artemisinin resistant marker (K13) in Plasmodium falciparum parasite populations of Grande Comore Island 10 years after artemisinin combination therapy
por: Huang, Bo, et al.
Publicado: (2015)

CSP—A Model for In Vivo Presentation of Plasmodium berghei Sporozoite Antigens by Hepatocytes
por: Balam, Saidou, et al.
Publicado: (2012)

Inhibition of In Vivo Growth of Plasmodium berghei by Launaea taraxacifolia and Amaranthus viridis in Mice
por: Adetutu, Adewale, et al.
Publicado: (2016)

Current status of experimental models for the study of malaria
por: Simwela, Nelson V., et al.
Publicado: (2022)

Lack of K13 mutations in Plasmodium falciparum persisting after artemisinin combination therapy treatment of Kenyan children
por: Muwanguzi, Julian, et al.
Publicado: (2016)

Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker
por: Tun, Kyaw M, et al.
Publicado: (2015)

The lack of K13-propeller mutations associated with artemisinin resistance in Plasmodium falciparum in Democratic Republic of Congo (DRC)
por: Yobi, Doudou Malekita, et al.
Publicado: (2020)

Mitigating the risk of antimalarial resistance via covalent dual-subunit inhibition of the Plasmodium proteasome
por: Deni, Ioanna, et al.
Publicado: (2023)

Anti-malarial resistance in Mozambique: Absence of Plasmodium falciparum Kelch 13 (K13) propeller domain polymorphisms associated with resistance to artemisinins
por: da Silva, Clemente, et al.
Publicado: (2023)

Design of proteasome inhibitors with oral efficacy in vivo against Plasmodium falciparum and selectivity over the human proteasome
por: Xie, Stanley C., et al.
Publicado: (2021)

Quantitative characterization of hemozoin in Plasmodium berghei and vivax
por: Pisciotta, John M., et al.
Publicado: (2017)

PKAc is not required for the preerythrocytic stages of Plasmodium berghei
por: Choudhary, Hadi Hasan, et al.
Publicado: (2019)

Inducible developmental reprogramming redefines commitment to sexual development in the malaria parasite Plasmodium berghei
por: Kent, Robyn S, et al.
Publicado: (2018)

In Vivo Antimalarial Activity of Annona muricata Leaf Extract in Mice Infected with Plasmodium berghei
por: Somsak, Voravuth, et al.
Publicado: (2016)

Antimalarial Activity of Croton macrostachyus Stem Bark Extracts against Plasmodium berghei In Vivo
por: Obey, Jackie K., et al.
Publicado: (2018)

Targeting the Cell Stress Response of Plasmodium falciparum to Overcome Artemisinin Resistance
por: Dogovski, Con, et al.
Publicado: (2015)

Impact of chrysosplenetin on the pharmacokinetics and anti-malarial efficacy of artemisinin against Plasmodium berghei as well as in vitro CYP450 enzymatic activities in rat liver microsome
por: Wei, Shijie, et al.
Publicado: (2015)

Polymorphisms in K13 and Falcipain-2 Associated with Artemisinin Resistance Are Not Prevalent in Plasmodium falciparum Isolated from Ugandan Children
por: Conrad, Melissa D., et al.
Publicado: (2014)

Imidazolopiperazines Kill both Rings and Dormant Rings in Wild-Type and K13 Artemisinin-Resistant Plasmodium falciparum In Vitro
por: Dembele, Laurent, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_udltvvt7nh6go492aedq0spp0s